These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10490811)

  • 21. Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2.
    Sakaue M; Adachi H; Dawson M; Jetten AM
    Cell Death Differ; 2001 Apr; 8(4):411-24. PubMed ID: 11550093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of v-src transformation by the drs gene.
    Inoue H; Pan J; Hakura A
    J Virol; 1998 Mar; 72(3):2532-7. PubMed ID: 9499119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell lines from grc congenic strains of rats having different susceptibilities to chemical carcinogens.
    Lu D; Kunz HW; Melhem MF; Gill TJ
    Cancer Res; 1993 Sep; 53(17):4089-95. PubMed ID: 8102943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of drs mRNA in human colon adenocarcinomas.
    Shimakage M; Kawahara K; Kikkawa N; Sasagawa T; Yutsudo M; Inoue H
    Int J Cancer; 2000 Jul; 87(1):5-11. PubMed ID: 10861446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression in transformed avian fibroblasts of a gene (crp) encoding a cysteine-rich protein containing LIM domains.
    Weiskirchen R; Bister K
    Oncogene; 1993 Sep; 8(9):2317-24. PubMed ID: 8361751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of decreased fte-1 gene expression on protein synthesis, cell growth, and transformation.
    Kho CJ; Wang Y; Zarbl H
    Cell Growth Differ; 1996 Sep; 7(9):1157-66. PubMed ID: 8877097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat fibroblasts expressing high levels of human c-myc transcripts are anchorage-independent and tumorigenic.
    Pellegrini S; Basilico C
    J Cell Physiol; 1986 Jan; 126(1):107-14. PubMed ID: 3944192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of a novel mouse variant of the drs tumor suppressor gene.
    Kawai T; Suzuki Y; Yamashita A; Inoue H
    Cancer Lett; 2002 Sep; 183(1):79-86. PubMed ID: 12049817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two proteins translated by alternative usage of initiation codons in mRNA encoding a JunD transcriptional regulator.
    Okazaki S; Ito T; Ui M; Watanabe T; Yoshimatsu K; Iba H
    Biochem Biophys Res Commun; 1998 Sep; 250(2):347-53. PubMed ID: 9753632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein A-1 is a negative target of v-Jun overexpression.
    Hadman M; Lin W; Bush L; Bos TJ
    Oncogene; 1998 Feb; 16(5):655-60. PubMed ID: 9482111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for cell-specific differences in transformation by N-, H- and K-ras.
    Maher J; Baker DA; Manning M; Dibb NJ; Roberts IA
    Oncogene; 1995 Oct; 11(8):1639-47. PubMed ID: 7478589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of elongation factor-1 delta (EF-1 delta) expression by oncogenes in human epithelial cells.
    Kolettas E; Lymboura M; Khazaie K; Luqmani Y
    Anticancer Res; 1998; 18(1A):385-92. PubMed ID: 9568107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of various human tumor cell lines by a dominant negative H-ras mutant.
    Ogiso Y; Sakai N; Watari H; Yokoyama T; Kuzumaki N
    Gene Ther; 1994 Nov; 1(6):403-7. PubMed ID: 7584106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of drs mRNA in colorectal neoplasms.
    Mukaisho K; Suo M; Shimakage M; Kushima R; Inoue H; Hattori T
    Jpn J Cancer Res; 2002 Aug; 93(8):888-93. PubMed ID: 12716466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains.
    Luo W; Wood CG; Earley K; Hung MC; Lin SH
    Oncogene; 1997 Apr; 14(14):1697-704. PubMed ID: 9135071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of anchorage-independent growth of ras-transformed cells on polyHEMA surface by antisense oligodeoxynucleotides directed against K-ras.
    Kawada M; Fukazawa H; Mizuno S; Uehara Y
    Biochem Biophys Res Commun; 1997 Feb; 231(3):735-7. PubMed ID: 9070883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of drs mRNA in human lung adenocarcinomas.
    Shimakage M; Takami K; Kodama K; Mano M; Yutsudo M; Inoue H
    Hum Pathol; 2002 Jun; 33(6):615-9. PubMed ID: 12152160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.